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ARTICLE
Suprachiasmatic VIP neurons are required for
normal circadian rhythmicity and comprised of
molecularly distinct subpopulations
William D. Todd1,7, Anne Venner 2,7, Christelle Anaclet3, Rebecca Y. Broadhurst2, Roberto De Luca2,
Sathyajit S. Bandaru2, Lindsay Issokson2, Lauren M. Hablitz 4, Olga Cravetchi4, Elda Arrigoni2,
John N. Campbell5, Charles N. Allen 4, David P. Olson 6 & Patrick M. Fuller 2✉
The hypothalamic suprachiasmatic (SCN) clock contains several neurochemically defined cell
groups that contribute to the genesis of circadian rhythms. Using cell-specific and genetically
targeted approaches we have confirmed an indispensable role for vasoactive intestinal
polypeptide-expressing SCN (SCNVIP) neurons, including their molecular clock, in generating
the mammalian locomotor activity (LMA) circadian rhythm. Optogenetic-assisted circuit
mapping revealed functional, di-synaptic connectivity between SCNVIP neurons and dor-
somedial hypothalamic neurons, providing a circuit substrate by which SCNVIP neurons may
regulate LMA rhythms. In vivo photometry revealed that while SCNVIP neurons are acutely
responsive to light, their activity is otherwise behavioral state invariant. Single-nuclei RNA-
sequencing revealed that SCNVIP neurons comprise two transcriptionally distinct subtypes,
including putative pacemaker and non-pacemaker populations. Altogether, our work estab-
lishes necessity of SCNVIP neurons for the LMA circadian rhythm, elucidates organization of
circadian outflow from and modulatory input to SCNVIP cells, and demonstrates a
subpopulation-level molecular heterogeneity that suggests distinct functions for specific
SCNVIP subtypes.
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Current understanding holds that circadian rhythms aregenerated within individual cells of the suprachiasmaticnucleus (SCN) and that cell–cell interactions within the
SCN network are required to sustain them1. One of the emergent
properties of these cell–cell circuit interactions is the circadian
period, a fundamental property of the SCN circadian clock2.
While the SCN contains a variety of neuropeptides3,4, as well as
the fast transmitter GABA5, that might variably contribute to
SCN network function and hence the ensemble period, previous
work has suggested an especially important role for SCNVIP cells
as “master pacemakers” of circadian rhythms6. In general support
of this view, developmental disruption of vasoactive intestinal
polypeptide (VIP−/− mice) or VIP signaling through its cognate
receptor, VPAC2 (Vipr2−/− mice), severely compromises both
synchrony among SCN neurons and behavioral rhythms6–8.
However, more recent studies have suggested an alternate view;
that is, a combination of neurons that express arginine vaso-
pressin (AVP)9, the dopamine 1a receptor (Drd1a)10, or non-VIP
neuromedin S (NMS)11 within the SCN, are hierarchically
dominant to SCNVIP neurons with respect to circadian pace-
making1. This hypothesis is surprising given that: (1) despite
alterations in circadian period, circadian rhythms are preserved
following disruption of the molecular clock in SCNAVP cells9, (2)
the effects of selective disruption of the molecular clock in
SCNVIP neurons have not been determined, and (3) the effect of
selective, non-germline ablation of SCNVIP neurons has also not
been tested.
Therefore, to more clearly and definitively delineate the role of
SCNVIP neurons in the regulation of circadian rhythms, in par-
ticular the question of necessity, here we selectively disrupted the
molecular clock in SCNVIP cells in mice and recorded circadian
rhythms of locomotor activity (LMA), body temperature (Tb),
sleep-wake, and wheel running activity. We also used a genetically
targeted ablation approach to selectively eliminate SCNVIP cells in
adult mice and compared this with genetically targeted lesions of
SCNAVP neurons and SCN GABA-ergic neurons, which enabled
us to evaluate the effect of non-germline disruption of SCNVIP
neurons on circadian rhythms. On the basis of the outcomes of
these physiological experiments, which identified necessity of
SCNVIP neurons in the regulation of the LMA circadian rhythm,
we then extended this experimental work to include a compre-
hensive interrogation of the cellular and synaptic properties of
SCNVIP neurons. To do so, we first employed fiber photometry to
evaluate the state-dependent activity dynamics of SCNVIP neu-
rons in vivo. We then used channelrhodopsin (ChR2)-assisted
circuit mapping (CRACM) to inform a more detailed under-
standing of the synaptic output pathways by which SCNVIP cells
may produce organismal-level rhythmicity. We similarly
employed modified rabies tracing to define synaptic inputs that
might modulate SCNVIP activity in vivo. Finally, we used high-
throughput single-nuclei sequencing (sNuc-seq) of SCNVIP cells
to determine whether SCNVIP neurons comprise distinct subtypes
and to define their molecular identities.
Results
Selective disruption of the molecular clock in SCNVIP cells.
Expression of the Bmal1 transcription factor within the cellular
SCN is both necessary and sufficient for coherent circadian
rhythmicity12,13. Whether or not a functional cellular clock in
SCNVIP neurons, which comprise ~10% of the cellular SCN
population4, is necessary for establishing and maintaining circa-
dian rhythms remains unclear. To explore this question, we first
generated VIP-IRES-Cre mice using previously described
recombineering techniques14 (see Methods). As shown in Fig. 1a,
our reporter cross (VIP-IRES-Cre::R26-loxSTOPlox-L10-GFP)
indicated that expression of the Cre transgene in our mice was
restricted to the ventrolateral (core) SCN. To generate mice
lacking a functional cellular clock in SCNVIP neurons, we crossed
our VIP-IRES-Cre mice with mice harboring floxed Bmal1 alleles
(Bmal1fl/fl)15. While mice homozygous for the VIP-Cre allele
showed the expected complete deletion of Bmal1 in SCNVIP
neurons, mice that were heterozygous for the VIP-Cre allele
continued to, unexpectedly, express Bmal1 in ~70% of VIP
neurons (Figure S1). We therefore measured the diurnal and
circadian rhythms of LMA and Tb in mice with: (1) complete
deletion of Bmal1 in SCNVIP neurons, and hence loss of the
molecular clock in these neurons (VIPcre/cre::Bmal1fl/fl); (2) partial
(VIPcre/wt::Bmal1fl/fl and VIPwt/wt::Bmal1fl/wt) and (3) no deletion
of Bmal1 in SCNVIP cells (VIPcre/cre) (Fig. 1B1-E2’). Under a
12:12 light-dark (LD) cycle, Bmal1-deleted mice exhibited a
consistent and significantly advanced phase angle of entrainment
(~3 h advance) in LMA and Tb (Fig. 1b) as compared to mice
with partial (Fig. 1C1-D2’) or no deletion (Fig. 1e) of Bmal1 in
VIP neurons, indicating altered synchronization to the external
LD cycle. When the VIPcre/cre::Bmal1fl/fl mice were released into
constant darkness (DD), their LMA rhythms slowly, but also
inexorably, became arrhythmic (Fig. 1 B1 and 1B2; 1G1),
demonstrating that the molecular clock in SCNVIP cells is
necessary for sustaining coherent circadian rhythms of LMA.
Despite clear visible effects on the amplitude and architecture of
the Tb waveform in DD (Fig. S2), our periodogram analysis
revealed that the Tb rhythm (Fig. 1B1’−2’), unlike the LMA
rhythm (Fig. 1B1-2), retained a circadian harmonic in the Bmal1-
deleted mice, with only two of the seven mice exhibiting a period
outside of the circadian range (18.5 and 27.7 h, Fig. 1G1’). We
finally noted that non-crossed VIPcre/cre mice (i.e., parent strain in
homozygous condition) under 12-12 LD conditions displayed a
more variable, although not statistically advanced or delayed,
phase angle of entrainment in LMA and Tb (Fig. 1F1-1’) as
compared with mice heterozygous for the cre allele or wild-type
littermate controls. VIPcre/cre mice also displayed a range of free
running Tb and LMA periods in DD (Fig. 1E1-2, 1E1’−2’; 1G1-1’)
that were comparable to those expressed by VIPcre/wt::Bmal1fl/fl
and VIPwt/wt::Bmal1fl/wt mice. We interpret the more variable
phase angle of entrainment as evidence of a possible hypomorphic
allele in the VIPcre/cre condition, although we did not observe a
reduction in VIP mRNA, and hence putative production of VIP,
in VIPcre/cre homozygous state as compared with mice hetero-
zygous for the cre allele or wild-type littermate controls (Fig. S3).
As a genetic comparator, we deleted Bmal1 in AVP neurons by
crossing AVP-ires-Cre mice14 with Bmal1fl/fl mice (AVPcre/cre::
Bmalfl/fl) and analyzed their LMA and Tb rhythms under LD and
DD (Fig. S4). We again found that complete deletion of Bmal1
required that the AVP-ires-Cre mice be in the homozygous state
(i.e., AVPcre/cre); unfortunately, this also produced profound dia-
betes insipidus in these mice, likely secondary to disruption of
AVP function (allele itself or Bmal1) in the supraoptic hypotha-
lamus. Regardless, we found that deletion of Bmal1 from AVP
neurons did not produce arrhythmicity in LMA or Tb under DD
conditions, but did result in a lengthening of the circadian period
of both rhythms (Fig. S4) in the AVPcre/cre::Bmalfl/fl mice, a finding
that recapitulates that previously reported by Mieda and collea-
gues9. Taken together, these findings clearly demonstrate that a
functional molecular clock in SCNVIP, but not SCNAVP, neurons
is necessary for circadian rhythms of LMA, and that the absence of
this clock in SCNVIP neurons also affects the expression, including
phasing and amplitude, of the circadian rhythm of Tb.
SCNVIP neurons and the circadian rhythm of sleep-wake. The
SCN plays an important role in regulating the timing and
architecture of the sleep-wake cycle16,17. Additional data suggest a
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possible role for the SCN in regulating the amount of sleep and
wake, although this remains a point of controversy18,19. A
decrease in rapid-eye movement (REM) sleep has also been
reported in VIP−/− mice20, although whether or not these effects
on REM sleep in the VIP−/− mice link to SCNVIP or extra-
SCNVIP regulation of REM sleep remains unclear. Regardless, the
cellular and synaptic bases by which the SCN clock, including
possibly SCNVIP neurons, might regulate the sleep-wake cycle
remains to be determined. Given our foregoing findings, we asked
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Fig. 1 Disruption of the molecular clock in SCNVIP neurons results in eventual loss of the LMA circadian rhythm. a Representative microphotographs at
three rostro-caudal levels of the ventrolateral SCN from a VIP-IRES-Cre::lox-L10-GFP reporter mouse reveals eutopic expression of GFP (scale bar, 300 μm;
n= 2). See also Fig. S1. b-e Representative actograms showing locomotor activity (LMA) and body temperature (Tb) circadian rhythms (gray scale: darker
represents higher temperature) and associated periodograms during at least 10 days in light/dark (LD), followed by at least three weeks in constant dark
(DD), followed by at least 7 days of LD from two VIPcre/cre::Bmal1fl/fl mice (b1-2, b1’-2’), two VIPcre/wt::Bmal1fl/fl mice (c1-2, c1’-c2’), two VIPwt/wt::Bmal1fl/wt
mice (d1-2, d1’-d2’) and two VIPcre/cre mice (e1-2, e1’-2’). Note a profound disruption of LMA rhythms in VIPcre/cre::Bmal1fl/fl mice (b1-2), whereas these
rhythms remain unaltered in VIPcre/wt::Bmal1fl/fl, VIPwt/wt::Bmal1fl/wt, and VIPcre/cre mice (c1-e2). See also Figure S2. Phase angle of entrainment for LMA (f1)
and Tb (f1’) in LD across all mice. Period length of LMA (g1) and Tb (g1’) in DD across all mice. Note that VIPcre/cre::Bmal1fl/fl mice (n= 6) display
significantly advanced phase angles of entrainment in LD for both LMA and Tb rhythms compared to VIPcre/wt::Bmal1fl/fl and VIPwt/wt::Bmal1fl/wt mice (n=
8), and VIPcre/cre mice (n= 5). (For LMA: 1-way ANOVA, F(2,16)= 27.57, P < 0.0001, Sidak’s post hoc: **P < 0.0001 and P < 0.0001; For Tb: 1-way ANOVA,
F(2,17)= 32.48, P < 0.0001, Sidak’s post hoc: **P < 0.0001 and P= 0.0002). In DD, VIPcre/cre::Bmal1fl/fl mice display period lengths outside of the circadian
range for LMA rhythms compared to VIPcre/wt::Bmal1fl/fl, VIPwt/wt::Bmal1fl/wt, and VIPcre/cre mice (note VIPcre/wt::Bmal1fl/fl and VIPwt/wt::Bmal1fl/wt mice are
included together as VIPcre/wt::Bmal1fl/fl in f–g). Means ± s.e.m. III, third ventricle; OC, optic chiasm; PV, paraventricular nucleus of the hypothalamus; SPZ,
subparaventricular zone; SON, supraoptic nucleus. See also Figs. S3 and S4.
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contribute to the regulation of the sleep-wake cycle. We did so by
recording the electroencephalogram (EEG) to monitor wake,
REM and non-REM (NREM) sleep, in the same cohorts of mice
as used for the Tb and LMA recordings, while mice were under
DD. We found that NREM sleep was increased at the beginning
of the subjective day in homozygous Bmal1-deleted mice as
compared to mice with partial Bmal1 deletions. And while we did
not observe an effect of genotype on the quantity of each vigilance
state, as measured over the 24 h period (Fig. 2a), we did find that
Bmal1-deleted mice exhibited decreased NREM sleep during the
subjective light phase, leading to an apparent redistribution of
sleep-wake activity (as demonstrated by a subjective dark to
subjective light ratio (SD/SL) that is closer to 1 (Fig. 2B2), sug-
gesting a potential role for SCNVIP neurons in regulating the
amplitude of the sleep-wake cycle. In order to test if disruption of
the molecular clock in SCNVIP neurons affected sleep quality, we
examined the vigilance state episodes during the SD and SL
periods, as well as performed an analysis of the cortical EEG
spectral power. Aside from sporadic individual differences in
wakefulness episode duration, Bmal1-deleted mice did not
demonstrate differences in sleep fragmentation or consolidation
as compared to mice with partial Bmal1 deletions (Fig. S5).
Similarly, cortical EEG power distribution across the 24 h day
revealed only a few significant differences, e.g., decreased delta
power during NREM sleep at one isolated time point, in fre-
quency bands between groups (Fig. S6).
Selective ablation of SCNVIP cells. Nearly all in vivo work to
date on SCNVIP neurons, including the foregoing experiments in
this study, have been performed in developmental mutant mod-
els, which have included transgenic crosses. While these models
have provided important insights into the neurobiology of the
SCN pacemaker, they also have important limitations, namely
that developmental disruption of transcription factors, receptors,
and neuropeptides, can complicate interpretation secondary to


































































SD/SL ratio% of 24 h
DD4 DD5DD4 DD5
SD/SL ratio% of 24 h
DD4 DD5DD4 DD5
SD/SL ratio% of 24 h
% of 12 h
% of 12 h













































































Fig. 2 Disruption of the molecular clock in SCNVIP neurons reduces the amplitude of the sleep-wake circadian rhythm. a Hourly amounts (mean ±
s.e.m.) of wakefulness (a1), NREM sleep (a2) and REM sleep (a3) in VIPcre/cre::Bmal1fl/fl (blue, n= 8) and VIPcre/wt::Bmal1fl/fl (red, n= 8) mice during the
4th and 5th day in constant darkness. b Upper panels: Amounts (mean ± s.e.m.) of the vigilance stages during the 4th and 5th subjective dark (SD4, SD5)
and subjective light (SL4, SL5) periods. Lower panels: 24 h amounts (mean ± s.e.m.) of the vigilance stages during the 4th and 5th day in constant darkness
(DD4, DD5; lower left panels) and subjective dark to subjective light (D/L) ratio for each vigilance stage during the 4th and 5th day in constant darkness
(lower right panels). n= 8 mice per genotype,*p < 0.05, **p < 0.01, two-way ANOVA followed by a post hoc Bonferroni test. See also Figs. S5 and S6. Note:
VIPcre/wt::Bmal1fl/fl and VIPwt/wt::Bmal1fl/wt mice are included together under VIPcre/wt::Bmal1fl/fl in all panels.
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signaling and overall network function10. We therefore pursued a
genetically targeted approach for chronically disrupting SCNVIP
neuron function in adult mice. To do this, we placed bilateral
injections of a viral vector expressing a Cre-dependent diptheria
toxin (DIO-DTA-AAV) into the SCN of VIP-IRES-Cre mice
(Fig. 3). We also placed bilateral injections of this same toxin into
the SCN of AVP-ires-Cre mice and Vgat-ires-Cre mice to serve as
genetic comparators. While the DIO-DTA-AAV has been pre-
viously validated21,22, and exhibits exquisite selectivity in pro-
ducing cell death, we confirmed histologically that bilateral
injections of this vector into the SCN of VIP-ires-Cre (VIPDTA)
and AVP-ires-Cre (AVPDTA) mice resulted in cell-specific abla-
tion, with no indication of “off target” cell death (Fig. 3a–i). As
shown in Fig. 3j–n, VIPDTA mice with complete lesions (n= 6;
>95% of VIP cell loss bilaterally) demonstrated a phase angle of
entrainment of LMA and Tb in LD that was significantly
advanced as compared with AVPDTA mice, and more strikingly,
both the Tb and LMA rhythms of these mice became severely
fragmented in DD, with all mice exhibiting periods outside of the
circadian range (12.33–30.5 h, shortest and longest tau; also see
DD Tb waveform in Fig S3). By comparison, AVPDTA mice with
complete lesions (n= 6) exhibited high-amplitude rhythms of
LMA and Tb in DD. Of note, AVPDTA mice did not show the
diabetic insipidus phenotype observed in the AVPcre/cre::Bmalfl/fl
mice, reinforcing the extra-SCN etiological basis of this pheno-
type. Finally, bilateral injections of DIO-DTA-AAV into the SCN
of Vgat-IRES-Cre mice approximated a near complete cellular
lesion of the SCN (due to the near ubiquitous expression of Vgat
in the cellular SCN23) and produced a more dramatic phenotype
than seen in the VIPDTA mice, including complete arrhythmicity
GFP
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of LMA and Tb in LD as well as in DD (Fig. 3l). The apparent
absence of light-masking by the LD cycle in the VgatDTA mice
may reflect the intensity of the light in our LD cycle, but may also
link to some DTA-induced cell loss in the dorsally adjacent
subparaventricular zone (SPZ), which is largely GABAergic
(Vgat+) and is a region previously shown to play a role in LD
masking24,25.
Selective ablation of SCNVIP cells and sleep-wake. We next
performed EEG analysis on the VIPDTA mice to determine the
effects of SCNVIP cell loss upon on the circadian rhythms of
sleep-wake (Fig. 4). Given the absence of LMA and Tb pheno-
types in the AVPDTA mice, and because they received the same
vector injections, we used these mice as comparators. As com-
pared to AVPDTA mice, VIPDTA mice exhibited a reduced cir-
cadian amplitude of the sleep-wake rhythm in DD. Selective
ablation of SCNVIP neurons did not produce significant changes
in vigilance stage episode number or duration (Fig. S7). However,
wakefulness and NREM sleep cortical EEG power circadian
variations appeared phase-reversed across all frequency bands
and at all vigilance stages (Fig. S8), resulting in significant dif-
ferences in power variation at multiple time periods between
AVPDTA and VIPDTA mice. These findings, in particular the
observed reduction in circadian amplitude, are largely consistent
to those in the VIPcre/cre::Bmal1fl/fl mice, reinforcing the inter-
esting possibility that SCNVIP neurons may exert an influence on
the expression of the sleep-wake rhythm, presumably by influ-
encing the level of arousal or sleep.
SCNVIP and wheel running behaviors. We next evaluated the
effects of (1) disruption of the molecular clock in SCNVIP neu-
rons, and (2) genetically driven ablation of SCNVIP neurons on
wheel running behavior in LD and DD. To do so, we generated
new cohorts of mice and evaluated wheel running rhythms in LD,
DD, and in a 1:11:1:11 skeleton photoperiod (SKP; Fig. 5a–e). In
contrast to the arrhythmic LMA phenotype observed in the
VIPcre/cre::Bmalfl/fl mice under DD (see Fig. 1 b1-b2), wheel-
running behavior in DD was strikingly normal in VIPcre/cre::
Bmalfl/fl mice (Fig. 5d) as compared with VIPcre/wt and VIPcre/cre
mice (Fig. 5a–b). Interestingly, however, we did observe mildly
abnormal wheel running behavior in three (of seven) of our
VIPcre/cre mice, taking the form of an immediate advance (~2–4
h) of wheel running activity on transition from LD to DD and a
lower amplitude/more fragmented circadian rhythm of wheel
running activity in DD (Fig. 5c), which we view as additional
evidence for a hypomorphic allele in the homozygous state. This
phenotype was not observed in the remainder of our VIPcre/cre or
VIPcre/wt controls, nor was it observed in any of the VIPcre/cre::
Bmalfl/fl mice (Fig. 5 d1-2), the latter suggesting that disruption of
the molecular clock in SCNVIP cells somehow compensated for
the putative hypomophic phenotype observed in some of the
VIPcre/cre mice. Compared to VIPcre/wt controls, which showed
the expected unitary bout of wheel running activity under the
1:11:1:11 SKP, all of the VIPcre/cre::Bmalfl/fl and VIPcre/cre mice
showed splitting (i.e., 2 daily bouts; Fig. 5b-d2) of their rhythms,
which is consistent with that previously reported in VIP knockout
(VIP−/−) and VIP receptor knockout (Vipr2−/−) mice6, and
continues to point to a potential hypomorphic condition in the
VIPcre/cre mouse. On the other hand, and similar to our telemetry
findings, wheel running rhythms in VIPDTA mice during DD
were severely disrupted. Despite appearance of arrhythmicity in
several mice, all but one VIPDTA mouse expressed a detectable
circadian component in their wheel running rhythms, although
the rhythms were low in amplitude and their period generally
shorter than that of the other groups (Fig. 5 e1-f). Hence the
genetically driven loss of SCNVIP neurons resulted in a wheel
running rhythm in DD that was similar, though not identical to
that previously reported in the congenital VIP and VPAC2 KO
models. Taken together, these findings suggest the interesting
possibility that non-photic sensory flow during wheel running
may provide an adequate forcing signal to ‘clockless’ VIP neurons
(i.e., VIPcre/cre::Bmalfl/fl mice), resulting in the appearance of a
consolidated wheel running rhythm. But in the absence of VIP
neurons (i.e., VIPDTA mice), and hence synaptic release of VIP,
GABA or other diffusible factors used by SCNVIP neurons, the
SCN is compromised in its ability to convey these non-photic
inputs to downstream intra- and extra-SCN effector circuits and
hence produce a high-amplitude rhythm of wheel running
activity. These results may also reflect a differential role for VIP in
circadian function across development, as acute ablation in
adulthood produces similar yet distinct phenotypes from genetic
germ-line deletions. It is also worth mentioning that while wheel
running behavior ostensibly provides another readout of SCN
phase and period, at least one prior study has raised the concern
that wheel running activity may not track with other physiolo-
gical readouts of SCN phase, especially when animals have altered
Fig. 3 Cell-type specific ablations of SCNVIP, but not SCNAVP, neurons result in loss of LMA circadian rhythm. (Top) DTA vector construct containing
non-Cre-dependent mCherry and Cre-dependent DTA sequences and schematic of AAV-DTA SCN injections in VIP-IRES-Cre, AVP-IRES-Cre and Vgat-
IRESCre mice. a GFP-expressing VIP neurons in the ventral SCN of a VIP-IRES-Cre::lox-L10-GFP mouse (representative example from n= 3 mice; scale bar,
150 μm). b Representative photomicrograph from a VIP-IRES-Cre::lox-L10-GFPmouse that received bilateral AAV-DTA injections. Note that GFP-expressing
SCNVIP neurons are absent but that surviving non-VIP neurons express mCherry (scale bar, 150 μm; n= 6). c Representative photomicrograph from a VIP-
IRES-Cre::lox-L10-GFP mouse that received a unilateral AAV-DTA injection. An asterisk marks surviving GFP-expressing SCNVIP neurons (cyan) on the non-
injected side whereas mCherry-labeled neurons (red) and the absence of GFP-expressing SCNVIP neurons on the contralateral side, indicate complete
unilateral ablation (scale bar, 150 μm; n= 6). d Higher magnification of dual-color box in (b), definitively confirming the absence of GFP (cyan) following
near total ablation of SCNVIP neurons (scale bar, 50 μm). e GFP-expressing AVP neurons in the dorsal SCN of a AVP-IRES-Cre::lox-L10- GFP mouse (scale
bar, 150 μm; representative example from n= 6 mice). f Representative photomicrograph from a AVP-IRES-Cre::lox-L10-GFP mouse that received bilateral
AAV-DTA injections. Asterisk marks surviving GFP-labeled (cyan) AVP cells (scale bar, 150 μm; n= 6). g, h Representative cases showing intact
immunolabelled (g) and L10-GFP (h) AVP neurons in the paraventricular nucleus (PVH) of two separate mice AVP-IRES-Cre::lox-L10-GFP that received
bilateral AAV-DTA SCN injections (scale bar, 150 μm; n= 6). i Intact AVP neurons in supraoptic nucleus (SON), same mouse as H (scale bar, 150 μm; n=
6). j, k Actogram (LMA, locomotor activity) and body temperature (Tb) (gray scale: darker represents higher temperature) during at least 7 days in light/
dark (LD), followed by at least 3 weeks in constant dark (DD), followed by at least 7 days of LD. j Bilateral ablation of SCNVIP neurons in a VIP-IRES-Cre
mouse disrupts LMA and Tb circadian rhythms. k Bilateral ablation of SCNAVP neurons in an AVP-IRES-Cre mouse leaves LMA and Tb rhythms intact.
l Bilateral ablation of SCNVgat neurons in a Vgat-IRES-Cre mouse abolishes all rhythmicity (n= 3). m In LD, ablation of SCNVIP neurons results in advanced
phase angles of entrainment. Lines represent mean ± s.e.m. (n= 6 VIPDTA mice, n= 7 AVPDTA mice; two-tailed unpaired t-tests: LMA, t(11)= 4.104, *p=
0.0017; Tb, t(11)= 4.036: *p= 0.002). n In DD, ablation of SCNVIP neurons results in periods outside circadian range, whereas ablation of SCNAVP neurons
maintains stable periodicity. Abbreviations: III, third ventricle; OC, optic chiasm.
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circadian phenotypes26. Our finding of similar, but also some-
what divergent not identical, effects of SCNVIP manipulation on
wheel running versus cage LMA is consistent with this prior
suggestion. We opted not to perform a similar experiment with
AVPcre/cre::Bmal1fl/fl mice due to concerns that they were too
sickly for the running wheel.
Activation of SCNVIP neurons does not drive sleep or arousal.
Given the significantly blunted circadian amplitude of the sleep-
wake cycle in both VIPcre/cre::Bmalfl/fl and VIPDTA mice, we asked
whether acute and selective activation of SCNVIP neurons might
increase sleep or wake (Fig. 6). To do this, we placed bilateral
injections of Cre-dependent hM3Dq into the SCN of hetero-
zygous VIP-ires-Cre mice (n= 4) as previously described27, and
administered the chemogenetic ligand clozapine-N-oxide (CNO;
0.3 mg/kg) at ZT4 (during the middle of the day when mice are
typically less active) or ZT13 (1 h after lights off, when mice are
typically most active). Strikingly, administration of CNO, which
produced robust expression of c-Fos in mCherry+ (hM3Dq+)
neurons, did not affect sleep-wake amounts (Fig. 6a), the number
and length of vigilance state episodes (Fig. 6b), or their dis-
tribution (Fig. 6c) at ZT13. Similarly, no changes in the cortical
EEG were observed in response to CNO administration (Fig. 6d).
Finally, circadian sleep-wake distribution was not affected by
activation of SCNVIP neurons in DD condition (Fig. 6f) and the
same results were obtained when CNO was injected at ZT4. These
findings suggest that SCNVIP neurons likely do not directly play a
role in the modulation of behavioral state, i.e., not wake- or sleep-
promoting per se. Rather, and instead, these findings inform the
more parsimonious explanation that the blunted circadian
amplitude of the sleep-wake rhythms observed in the VIPcre/cre::
Bmal1fl/fl mice and VIPDTA mice were secondary to changes (i.e.,
arrhythmicity and fragmentation) of the LMA rhythm.
Light but not behavioral state alters SCNVIP cell activity. To
help reconcile the observed reduction in the amplitude of the
sleep-wake cycle in the VIPcre/cre::Bmal1fl/fl mice and VIPDTA
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Fig. 4 Cell-type specific ablation of SCNVIP neurons, but not SCNAVP neurons, reduces the amplitude of the sleep-wake circadian rhythm. a Hourly
amounts (mean ± s.e.m.) of wakefulness (a1), NREM sleep (a2), and REM sleep (a3) in AVP-IRES-Cre (AVPDTA; gray, n= 6 mice) and VIP-IRES-Cre
(VIPDTA; gray, n= 6 mice) that received bilateral injections of DTA vector into the SCN, during the 4th and 5th day in constant darkness. b Upper panels:
Amounts (mean ± s.e.m.) of the vigilance stages during the 4th and 5th subjective dark (SD4, SD5) and 4th and 5th subjective light (SL4, SL5) periods.
Lower panels: 24 h amounts (mean ± s.e.m.) of the vigilance stages during the 4th and 5th day in constant darkness (DD4, DD5; lower left panels) and
subjective night to subjective day (D/L) ratio for each vigilance stage during the 4th and 5th day in constant darkness (lower right panels). n= 6 mice per
group,*p < 0.05, **, two-way ANOVA followed by a post hoc Bonferroni test. See also Figs. S7 and S8.
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SCNVIP neurons on sleep or wake, we next examined the state-
dependent population Ca2+ activity dynamics of SCNVIP neurons
using in vivo fiber photometry (Fig. 7). To do so, we placed
unilateral injections of DIO-GCaMP6s-AAV10 into the SCN of
VIPcre/wt mice and implanted a photometry fiber immediately
dorsal to the SCNVIP cell bodies (Fig. 7a–c). Four-six weeks after
injections of the viral vector, mice were habituated to the
recording conditions before being placed in DD at ZT12. After
the mice were released into DD, on the next day, simultaneous
sleep-wake and photometry recordings were carried out at CT
2–5 and CT 12-15 with a 20-min light pulse applied at CT14 (i.e.,
26 h after onset of DD, Fig. 7d). SCNVIP neurons were immedi-
ately activated by the light pulse (Fig. 7e–g), indicating that light
stimulation at the retina results in robust excitation of the
SCNVIP cell population. As an important control, VIP-containing
neurons in the rostrally adjacent ventromedial preoptic nucleus
(VMPO) were not activated by the light pulse (Fig. S9 A-B),
indicating that neuronal activation by light is selective to SCNVIP
neurons and not simply an artifact of external light pollution.
Following the initial peak induced by the light pulse, Ca2+ activity
declined to baseline levels. Interestingly, further Ca2+ peaks were
observed throughout the remainder of the light pulse when the
mice were awake, but not when they were in NREM or REM sleep
(Fig. 7e). These peaks in Ca2+ activity were only observed during
the 20-min light pulse and did not occur during waking episodes
either prior to, or immediately after the cessation of, the light
pulse (Fig. 7h), nor were they present during wake in the absence
of light—hence this was not a movement artifact. Apart from the
activity observed during the light pulse, the activity profile of
SCNVIP neurons did not fluctuate significantly over sleep-wake
states or at arousal state transitions, and this was independent of
the time of day (Fig. S9C-I). In sum our findings show that the
SCNVIP population is highly responsive to light input in vivo,
which is congruent with a recent report28, but also that their
activity is behavioral state independent. The latter observation is
consistent with our chemogenetic findings which suggest that
SCNVIP neurons may not contribute directly to the regulation of
sleep-wake architecture, timing or amounts.
Mapping functional synaptic outflow of SCNVIP cells. While
the foregoing work points to an indispensable role for SCNVIP
neurons in producing coherent circadian rhythms of LMA, the
post-synaptic targets by which SCNVIP neurons drive the LMA
rhythm (or nearly any output rhythm) remain incompletely
understood. To initially map efferent projections of SCNVIP
neurons we placed unilateral injections of a genetically encoded
anterograde tracer into the SCN of VIPcre/wt mice. As shown in
Fig. S10, intra-hypothalamic and preoptic regions were primary
targets of SCNVIP neurons. The presumptive terminal fields
within the dorsomedial hypothalamus (DMH) were of particular
interest given previous lesion studies that identified an important
role for the DMH in the expression of the LMA circadian
rhythm29. The density of SCNVIP terminal fields within the DMH
was nevertheless rather modest, suggesting that a portion of
SCNVIP inputs to the DMH may be indirect (polysynaptic). To
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Fig. 5 Circadian rhythms of wheel running behavior remain intact following loss of the molecular clock in SCNVIP neurons, whereas their ablation
disrupts this rhythm. a–f Wheel running behavior and associated periodograms from a control VIPcre/wt mouse (a), two VIPcre/cre mice (b, c), two
VIPcre/cre::Bmal1fl/fl mouse (d), two VIPcre/wt mice that received bilateral injections of the DTA vector into the SCN (e) and a VIPcre/cre mouse that received
bilateral injections of the DTA vector into the SCN (F) under a 12:12 light-dark (LD, 10 days) cycle, in constant darkness (DD, 22 days), and under a
1:11 skeleton photo period (14 Days). Surprisingly, VIPcre/cre::Bmal1fl/fl mice show intact rhythms of wheel running behavior following genetic deletion of
Bmal1 in SCNVIP neurons. However, cell-specific ablation of SCNVIP in VIPDTA mice (both homozygous and heterozygous for the VIP-Cre gene) results
in severe disruption of the wheel running rhythm. g Left, phase angle of entrainment for wheel running behavior in LD across all mice. (VIPcre/wt, n= 3;
VIPcre/cre, n= 6; VIPcre/wt::Bmal1fl/fl, n= 4; VIPcrecre::Bmal1fl/fl, n= 9; VIPDTA, n= 4). Right, period length in DD across all mice reveals that cell-specific
ablations (VIPDTA) results in periods of wheel running behavior that, while disrupted, retain a circadian component. Means ± s.e.m. LDΨ= phase angle of
entrainment, i.e., difference in hours between LD transition (ZT12) and rhythm acrophase. DDτ= free running period length.
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a polysynaptic pathway, involving the SPZ, in regulating the
circadian rhythm of LMA29,30. We therefore asked whether
SCNVIP neurons are functionally, synaptically coupled with
DMH neurons via the SPZ. Indeed, a SCN→ SPZ→DMH cir-
cuit has been previously proposed29,31, but never functionally
confirmed.
To assess functional polysynaptic connectivity, we first tested
whether SCNVIP neurons inhibit SPZ neurons that project to the
DMH (SCNVIP→ SPZ→DMH) by performing Channelrhodop-
sin(ChR2)-assisted circuit mapping (CRACM) in brain slices, as
previously described32,33. We expressed ChR2-mCherry in
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the SCN of VIPcre/wt mice. In the same mice, we placed injections
of green-fluorescent CTB (F-CTB) into the ipsilateral DMH. Five
to six weeks later, we recorded from SPZ neurons that were
retrogradely labeled from the DMH while photostimulating fibers
and terminals from SCNVIP neurons in SPZ (Fig. 8a). Of the 20
recorded SPZ-DMH projecting neurons, we labeled 11 of these
neurons with biocytin and confirmed that they were located in
the SPZ (Fig. 8b–c). Histological assessment confirmed that
expression of ChR2-mCherry and F-CTB were restricted to the
SCN and DMH, respectively (Fig. 8d–e). Photostimulation of the
SCNVIP→ SPZ input inhibited action potential firing, and evoked
inhibitory postsynaptic currents (IPSCs) in 6 out of 20 SPZ→
DMH projecting neurons (Fig. 8f–g). The probability of a
connected cell responding to photo-stimulation was 97.78 ±
1.65%, the average photo-evoked IPSC peak amplitude was
107.20 ± 26.88 pA and the photo-evoked IPSC latency was 9.97 ±
0.84 ms. These findings confirm that SCNVIP cells are function-
ally synaptically coupled, via a cellular SPZ relay, with DMH cells
and identify a circuit substrate by which SCNVIP neurons may
regulate LMA rhythms. These results also re-emphasize the
functional and anatomical importance of the cellular SPZ as a
postsynaptic target of, and relay for, SCN neurons and their
synaptic outflow33–35.
Photic and non-photic presynaptic inputs to SCNVIP cells.
While previous studies using conventional tracing techniques
have identified inputs to the SCN, these approaches have lacked
specificity, particularly with respect to defining afferents to spe-
cific SCN cell types, including SCNVIP neurons. We therefore
sought to determine the extra-SCN sources of synaptic inputs to
SCNVIP neurons using conditional monosynaptic retrograde
rabies tracing (Fig. 9a). As shown in Fig. 9b, c, the starter
population of VIP neurons was restricted to the SCN. Many
retrogradely labeled neurons were observed in the lateral septum
(LS), the bed nucleus of the stria terminalis (BNST), the septo-
hypothalamic nucleus (SHy), the medial preoptic (MPO), the
VMPO, the anteroventral periventricular nucleus (AVPe), the
paraventricular thalamic nucleus (PVA), the ventromedial
hypothalamic nucleus (VMH), the arcuate nucleus (ARC), the
DMH, the intergeniculate leaflet (IGL) and scattered throughout
the retina (Fig. 9d–j). Our findings are broadly consistent with
other studies describing afferents to the SCN in the hamster36,
rat37,38, and mouse39. However, and unlike these previous studies,
we did not observe retrogradely labeled neurons in the hippo-
campus or dorsal raphe nucleus. Altogether, our results therefore
confirm and extend previous anatomic studies in establishing
SCNVIP as post-synaptic targets of key brain structures involved
in mediating photic and non-photic influences on the clock.
SCNVIP neurons comprise two molecularly distinct subtypes.
Previous studies in rodent models have raised the possibility that
SCNVIP neurons are a heterogenous population containing ana-
tomically and physiologically distinct subtypes40,41. However, the
molecular identity of these subtypes and the full extent of their
differences remain unclear. We therefore used sNuc-Seq42, a
systematic means of classifying cell types based on the nuclear
mRNA profiles of single cells, to characterize the molecular
diversity of SCNVIP neurons. First, to label VIP neuron nuclei for
sampling, we crossed VIP-IRES-Cre mice to a transgenic reporter
mouse line that Cre-dependently expresses a nuclear-localized
mCherry (H2b-TRAP)43. We then performed sNuc-Seq on
mCherry+ cell nuclei sorted from juvenile and adult male VIP-
IRES-Cre::H2b-TRAP SCN tissue that had been dissected one
hour after light cycle onset (Fig. 10a). We sequenced each of 192
single-nuclei samples to a depth of 3.0 M ± 1.4M reads per
sample, aligned the reads to the mouse genome (mean and S.D.
reads aligned per sample, 79% ± 22%), and quantified expression
values based on the number of reads aligning to each gene
(see “Methods”). After filtering out the 7% of samples in which
fewer than 500 genes were detected, we used the remaining 178
single-nuclei transcriptomes, averaging (±S.D.) 3694 ± 1425 genes
each, for unsupervised clustering and differential expression
analysis.
Our initial results showed three clusters of VIP neurons
(Fig. S11A). Each cluster contained cells from each age group
(Fig. S11A), indicating that the transcriptional identities of
these groups are stable across late development and thereby
justifying our pooling of the data for analysis. However, only two
of the three initial clusters were confirmed as SCN neurons based
on their expression of the regional marker genes, Lhx1 and
Vipr244,45 (Fig. S11B) and so were the focus of our subsequent
analysis.
Re-clustering only the neurons that contained SCN marker
genes revealed two subtypes of SCNVIP neurons with distinct
transcriptional profiles (Fig. 10b, c). We annotated these two
subtypes as GrpVIP neurons and NmsVIP neurons based on their
enriched expression of the neuropeptide-encoding genes. These
subtypes are consistent with the two VIP neuron subtypes,
similarly called Vip/Grp neurons and Vip/Nms neurons,
identified by a study published during the revision of this
manuscript (Fig. S11C). Contrasting their transcriptional profiles
revealed gene sets which are consistent with distinct functional
roles. For instance, consistent with a central role in circadian
clock function, NmsVIP neurons were enriched with transcripts
encoding components and regulators of the circadian clock,
including: Per2; salt inducible kinase 1 (Sik1)46; Prok247, and
Prokr248. On the other hand, GrpVIP neurons had higher
expression of GABA receptor genes (Gabra2, Gabrg1, Gabrb1)
Fig. 6 Chemogenetic activation of SCNVIP neurons does not acutely promote sleep or wake. a–d Mice expressing the excitatory receptor hM3Dq in
SCNVIP neurons (n= 4) were injected with CNO (0.3 mg/kg, IP) or vehicle (saline) at 7 P.M. (ZT13). a Amount (mean ± s.e.m.) of the vigilance stages
during the 4 h period following injections and of the remaining dark period. b Number of episodes (mean ± s.e.m.) of wake, NREM sleep or REM sleep
binned in varying episode lengths and c time-weighted frequency histograms showing the percentage (mean ± s.e.m.) of wake, NREM sleep or REM sleep
amounts binned for each episode length with respect to the total amount of wake, NREM sleep or REM sleep during the 4 h period following injections.
d Cortical EEG power band changes from baseline. Delta (δ: 0.5–5 Hz), theta (θ: 5–9 Hz), sigma (σ: 9–15 Hz), beta (β: 15–30 Hz), low gamma (lγ:
30–60 Hz) and high gamma (hγ: 60–120 Hz) power band (mean ± s.e.m.) changes during the 3 h period following injections. e Left: Native mCherry
fluorescence showing the AAV-hM3Dq-mCherry injection site in a VIP-IRES-Cre::loxGFPL10mouse (scale bar, 200 μm). Boxed area magnified and shown in
the green color channel (right) illustrating robust expression of c-Fos in SCN neurons following administration of 0.3 mg/kg CNO (scale bar, 50 μm).
f hM3Dq expression in the SCN of a VIP-IRES-Cre::lox-L10-GFP mouse, demonstrating that hM3Dq-mCherry was expressed eutopically. g Hourly amounts
of wake, NREM sleep and REM sleep in baseline (LD) condition, during the 3rd day of constant darkness (DD3), following CNO (0.3 mg/kg) injection at
7 P.M., on the 4th day of constant darkness (DD4) and during the 5th day of constant darkness (DD5). a–d, g No significant difference, two-way ANOVA
followed by a post hoc Bonferroni’s test. III, third ventricle; OC, optic chiasm.
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and androgen receptors (Ars) and therefore GrpVIP SCN neurons
may be an important cellular point of entry to the SCN clock for
non-photic inhibitory inputs, including androgens that can
potently alter the circadian period49,50.
Technical consideration: a hypomorphic allele? While our
physiological and behavioral recordings in the VIPcre/cre mouse
are potentially consistent with a hypomorphic allele, the expres-















































































































































































Fig. 7 In vivo fiber photometry reveals SCNVIP neurons are activated by light stimulation of the retina. a Experimental schema showing viral vector
targeting and headset equipment for simultaneous in vivo fiber photometry and EEG/EMG recordings from mice expressing GCaMP6s in SCNVIP neurons.
b Representative photomicrograph of GCaMP6s expression in the SCN and location of the photometry optical fiber. Scale bar: 200 µm. OC; optic chiasm,
III; 3rd ventricle. c Schematic of SCN area showing fiber placement from experimental mice over the SCN. d Behavioral experimental paradigm showing
times of photometry/EEG recording related to the time of day and the light pulse stimulus. e Representative example showing GCaMP6s signal (upper
panel), EEG frequency spectrogram (2nd panel from top), raw EEG (3rd panel from top) and raw EMG (bottom panel) before, during and after the 20-min
light pulse at ZT14. Red dotted rectangle indicates time displayed in (f, g). f Mean GCaMP6s activity over all mice at the initiation of the light pulse. Black
dotted line indicates onset of the light pulse. Shaded area indicates s.e.m. Paired t-test (two-tailed) * <0.0206. n= 4. g Heatmap depicting GCaMP6s
activity at the light pulse for each mouse. White dotted line indicates onset of the light pulse. hMean (+ s.e.m.) GCaMP6s activity during wake and NREM
sleep before, during and after the light pulse. RM two-way ANOVA (Interaction: Light Pulse x Arousal State F (2, 6) = 62.82, p < 0.0001; n= 4 followed by
Sidak’s post hoc tests (*p < 0.05, **p < 0.01, ****p < 0.0001)). See also Fig. S9.
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number of VIP+ cell bodies (per GFP+ cells in the genetic cross)
within the SCN did not appear to be appreciably altered in the
homozygous state. It is nevertheless possible, however, that less
VIP was being produced in the SCN of the homozygous VIPcre/cre
mouse, as has been reported before in other targeted transgenic
IRES-Cre mouse lines21, and as was clearly the case for the Vip-
IRES-Cre (JAX #010908) mouse line that has been employed in a
number of previous chronobiology studies51. If it were the case
that less VIP was produced in the SCN of our mice, however, the
mild phenotypes observed in the hypomorph would only
emphasize the importance of VIP in proper SCN network func-
tion (i.e., other SCN cell populations are apparently unable to
fully compensate for the presumptive decrease in VIP produc-
tion). As another consideration, SCNVIP neurons co-express and
release GABA, and as such it is possible that GABA-VIP synaptic
“balance” may have been disrupted in the VIPcre/cre mouse and
thereby contributed to the phenotypes (e.g., high variability in the
phase angle of entrainment of Tb and LMA). To begin to explore
this interesting possibility, we selectively disrupted GABAergic
signaling by VIP neurons to see if this would “rescue” the mild
circadian phenotype observed in our VIPcre/cre mice. To do so, we
generated VIPcre/cre::Vgatfl/fl mice. Rather remarkably, we found
that disruption of GABAergic signaling by VIP neurons in the
VIPcre/cre mouse (putative hypomorphic) reduced the variability
in the LD phase angle of entrainment for Tb, but not for LMA
(Fig. S12). While a finding that could have explanatory power for
the previously reported “desynchronizing” effects of SCN GABA
as well as implications for the molecular basis of entrainment,
future intersectional studies will be needed to better understand
the functional relationship between GABA and VIP synaptic
release by SCNVIP and their individual roles in SCN circuit
function.
Discussion
Altogether considerable evidence has accumulated pointing to an
important role for VIP, and its cognate receptor, VPAC2, in SCN
clock function, yet more recent studies have suggested that other,
non-VIP SCN cell groups may play a more dominant role in
circadian pacemaking. Here we show that SCNVIP neurons, and
their internal molecular clock, are in fact necessary for estab-
lishing and maintaining coherent circadian rhythms of LMA, and
for the normal expression of the circadian rhythms of Tb, sleep-
wake and wheel running behavior. While our findings do not




































Fig. 8 SCNVIP neurons inhibit SPZ neurons that project to the DMH (SCNVIP→ SPZ→DMH). a Schematic of the experimental design used to map
SCNVIP→ SPZ→DMH connectivity in brain slices. AAV-DIO-ChR2-mCherry was injected into the SCN of VIPcre/wt mice and in the same animals, green-
fluorescent CTB (F-CTB; Alexa Fluor-488 conjugated-CTB) was injected into the ipsilateral DMH, to retrogradely label SPZ neurons that project to the
DMH. Recordings were made from SPZ neurons labeled with F-CTB in green while photostimulating SCNVIP axon terminals in the SPZ. b Examples of SPZ
neurons retrogradely labeled (upper panels) from the DMH and imaged during whole-cell recordings under fluorescent and IR-DIC visualization (lower
left) or after post hoc labeling of biocytin with streptavidin-conjugated AlexaFluor-405 (blue; lower right). Scale bar: 20 µm). c Map of 11 recorded SPZ
DMH projecting neurons identified after post hoc labeling of biocytin (scale bar: 500 µm). d Photomicrograph, illustrating ChR2-mCherry expression in
SCNVIP neurons (marked by arrows) at low (left; scale bar: 100 µm) and higher (right; scale bar: 20 µm) magnifications. e Heatmap of the distribution of F-
CTB in the DMH in five recorded mice (left) and an example of green F-CTB in the DMH (right; scale bar: 200 µm). f, g Photostimulation of SCNVIP input
inhibited action potential firing of SPZ DMH projecting neurons (f cell-attached recording, blue bar represents a 10-s train stimulation at 10 Hz; 10ms light
pulses) and in the same neuron in whole-cell configuration, elicited photo-evoked IPSCs (g blue bar represents a 10-ms light pulse; Vh= 0mV). Individual
photo-evoked IPSCs are shown in gray and the average trace in black. OC: optic tract; III third ventricle.
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contribute to the regulation of the sleep-wake cycle, both the
absence of an effect of acute chemogenetic activation of SCNVIP
neurons on sleep-wake, and our finding that the activity
dynamics of SCNVIP neurons are behavioral state invariant,
instead support the null hypothesis. Regardless, our in vitro
CRACM experiments establish the presence of a functional
SCNVIP→ SPZ→DMH synaptic pathway by which these neu-
rons may regulate circadian rhythms of LMA. We also found that
SCNVIP neurons are post-synaptic targets of key structures
mediating non-photic and photic modulation of the SCN clock
and hence likely comprise a cellular point of integration of these





















































NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-17197-2 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4410 | https://doi.org/10.1038/s41467-020-17197-2 |www.nature.com/naturecommunications 13
SCNVIP neurons, NmsVIP neurons, express core components and
regulators of the circadian clock, inferring pacemaker potential,
and that another subset of SCNVIP neurons, GrpVIP, more
uniquely expresses high levels of GABA and Ars and hence may
function as cellular effectors for non-photic inputs, including
gonadal hormones.
In the present study, we found that developmental disruption
of the molecular clock within SCNVIP neurons produced, in DD,
arrhythmicity in LMA and altered the expression of the Tb and
sleep-wake rhythms. Selective, genetically driven ablation of
SCNVIP neurons in adult mice recapitulated the arrhythmic LMA
phenotype but also profoundly altered the expression of Tb and
wheel-running activity rhythms. With respect to other established
pacemaker cell populations, seminal work by Lee and colleagues
found that a subset of SCN neurons expressing NMS (~45–50%
of total SCN neuronal population) plays an essential role in the
Fig. 9 Presynaptic inputs to SCNVIP neurons arise from areas involved in photic and nonphotic sensory regulation of the SCN clock. a Schematic of
experimental procedure. AAV8-DIO-TVA-mCherry and AAV8-DIO-RG were co-injected into the SCN of VIP-IRES-Cre mice at Day 1. 28 days later, the
pseudotyped modified rabies virus (EnvA-ΔG-eGFP) was injected at the same site in the SCN and the mice perfused 11 days later. b Photomicrograph of
the SCN illustrating AAV8-DIO-TVA-mCherry expressing neurons (magenta) and EnvA-ΔG-eGFP expressing neurons (green). Co-expression of AAV8-
DIO-TVA-mCherry and EnvA-ΔG-eGFP represents the starter population. Scale bar: 200 µm. (C1–3) High magnification image of box in B (C1), red
channel only (C2) and green channel only (C3). Filled arrows point towards starter population neurons expressing both AAV8-DIO-TVA-mCherry
and EnvA-ΔG-eGFP. Unfilled arrows point towards neurons expressing EnvA-ΔG-eGFP only (retrogradely labeled neurons). Scale bar: 100 µm.
d–h Photomicrographs showing SCNVIP brain input populations in: LS, BNST and SHy (d); VMPO, MPO, AVPe (e); PV (f); Arc, VMH, DMH (g); IGL and PH
(h). Scale bar: 200 µm. i Photomicrograph of retina showing EnvA-ΔG-eGFP expressing neurons (green, filled arrows), counter-stained with DAPI. Scale
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Fig. 10 sNuc-seq analysis reveals two transcriptionally distinct populations of SCNVIP neurons. a Schematic of method for labeling, isolating, and
profiling SCNVIP neuron transcriptomes for sNuc-Seq; images are from samples used in this study. b t-Distributed Stochastic Neighbor Embedding (tSNE)
plot of 144 VIP SCN neurons (dots) profiled by sNuc-Seq and clustered according to their expression of 689 high-dispersion genes; colors indicate cluster
identity. c Heatmap showing single-cell (column) expression of top cluster marker genes (rows), with cells (columns) binned by cluster identity. d Violin
plots of single-cell expression values of Vip and selected cluster marker genes. See also Fig. S11.
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generation of daily rhythms in behavior11. These authors speci-
fically showed that disruption of the molecular clock in NMS
neurons produces arrhythmic wheel running activity and,
moreover, that NMS neurons control in vivo circadian rhythms
through intercellular synaptic transmission. Our data suggest the
possibility that the arrhythmic phenotype observed in the NMS
mice experiments may link to disruption of the NmsVIP popu-
lation. The fact that non-VIP NMS, including GrpVIP or AVP,
cells were unable to compensate for the absence of NmsVIP
neurons, underscores this point. Our findings are moreover
consistent with recent findings by two different groups who
reported that activation or inhibition of VIP cells in vivo can
acutely modulate LMA rhythms40,52.
In a recent study Jones et al.28 showed, using in vivo fiber
photometry, that SCNVIP neurons exhibit circadian rhythms of
spontaneous activity, are acutely responsive to light, and are
essential for the normal resetting of daily rhythms by environ-
mental light. Using a similar approach, but here in combination
with chronic EEG recordings, we also found that SCNVIP cells are
highly responsive to light, but that their activity is otherwise
behavioral state invariant. During a light pulse administered at
CT14 we were surprised to observe additional Ca2+ peaks that
occurred selectively when mice were awake but not when they
were in NREM or REM sleep. It is thus tempting to speculate that
the Ca2+ activity peaks uniquely observed during the light pulse
and waking condition reflect integration of non-photic (e.g.,
locomotor, head movement or other signals associated with wake)
and photic sensory flow by SCNVIP neurons53,54. This hypothesis
derives additional support from our anatomic findings that
revealed inputs to SCNVIP neurons from both the retina and the
IGL, the latter structure long-implicated in non-photic resetting
of the clock55. Put another way, our anatomic findings show that
SCNVIP neurons can be presynaptically modulated by both photic
and non-photic sensory flow, and taken together with our pho-
tometry findings, suggest the interesting possibility that SCNVIP
neurons may actually represent a key cellular point of integration
of these sensory inputs. To this end, we also noted substantial
input from several preoptic cell groups, suggesting a potential
circuit substrate by which temperature sensitive neurons might
modulate, and possibly entrain, SCNVIP neurons56. It is also
useful to contrast our findings with those from a recent rabies-
based tracing study57 which showed that CCK-expressing SCN
neurons, which are generally intermingled with, but are also
distinct from, SCNVIP neurons, receive input from a large
number of hypothalamic and preoptic structures, but not from
the retina, and minimally from the IGL.
Our findings of molecular heterogeneity within the SCNVIP cell
population considerably extend findings from previous studies.
For example, Kawamoto et al.41 demonstrated that SCNVIP
neurons can be divided into two groups based on light-
inducibility of the Per1 gene, innervation of retinal afferents,
day-night variation in VIP mRNA, and the coexpression of GRP.
Similarly, Mazuski et al.40 found two classes of instantaneous
firing activity in SCNVIP neurons. Our finding that Sik1 is pri-
marily expressed in NmsVIP, i.e., GRP-negative subtype, of
SCNVIP neurons, provides an important functional-anatomical
framework for the findings by Jagannath et al.46 who showed that
Sik1 and CREB-regulated transcription coactivator 1 (CRTC1)
are involved in clock resetting. In addition, Model et al.58 had
previously shown that gonadectomy influences circadian period
by acting directly on the SCN, and that Ars are located in the
ventrolateral SCN49. While the cell type expressing the Ars
remained unclear, localization to SCN GRP-positive cells has
been suggested49. Our transcriptional data confirm that Ars are
localized to the GrpVIP cells and provides additional evidence of
the potent influence that even a subset of SCNVIP neurons can
have on ensemble period, although an additional contributing
influence of non-VIP GRP SCN neurons that also harbor Ars
cannot be discounted. It has also been shown that SCN photic
sensitivity can be modulated by changes in the endocrine
milieu49,50, which provides yet another compelling indication that
SCNVIP/GrpVIP neurons integrate photic and non-photic inputs
to modulate the output of the SCN clock. Our transcriptional
profile of GrpVIP SCN neurons also raises the possibility that
GRP-VIP neurons are non-circadian as they lack detectable clock
gene expression. While it is possible that GrpVIP neurons express
circadian genes at other time points or under other conditions,
the depth of sequencing we achieved would argue against our
negative finding reflecting a failure of detection. Interestingly, a
lack of detectable rhythmicity in clock gene expression in SCN
GRP cells was previously reported59. Hence it is unlikely that
GrpVIP SCN neurons possess endogenous circadian pacemaker
potential, but rather are entrained through coupling to SCN
NmsVIP pacemaker cells. Our sNuc-Seq findings also lend addi-
tional support to the surmise that the phenotypes observed in the
NMS mice link, at least in part, to disruption of the NmsVIP
population, given that this subpopulation was enriched with
transcripts encoding components and regulators of the circadian
clock. Finally, the finding of molecular heterogeneity provides
another example of apparent conserved features between VIP
and pigment dispersing factor (PDF), which is a neuropeptide
related to VIP that is found in insect circadian systems and
whose cell bodies appear to be comprised of two distinct
subpopulations60,61.
While SCNVIP neurons comprise only ~10% of the total cel-
lular SCN, our findings indicate an indispensable role for this cell
population in the regulation of the LMA rhythm as well as for the
normal expression of the Tb, sleep-wake and wheel-running
rhythms. Specifically, we found that other neuropeptide systems
in the SCN network, in either the acute or developmental fra-
mework, were unable to compensate for the loss of SCNVIP
neurons, or their cellular clocks, to maintain coherent LMA
rhythms or high-amplitude Tb and sleep-wake rhythms. Given
differential disruptive effects of our SCNVIP cell manipulations on
LMA, Tb, sleep-wake, and wheel running rhythms, our findings
also lend support to a model in which neurochemically defined
SCN cell groups utilize differential synaptic outflow pathways and
downstream circuit targets to impart circadian timing informa-
tion on a wide range of physiological and behavioral processes.
This model derives additional support from a recent paper by
Paul and colleagues who showed that selective manipulation of
SCNVIP cells can acutely modulate cardiovascular function, likely
via direct synaptic inputs to pre-autonomic neurons within the
dorsal cap of the PVH (a region we also found to be a dense post-
synaptic target of SCNVIP cells—see Fig. S10)52. Our results
further align with findings in aging humans, wherein the LMA,
rhythm is disrupted in association with loss of SCNVIP neurons62
and also with recent findings linking a polysynaptic
SCNVIP→VMH circuit with rhythms of aggression33.
The present study also provides a template for future experi-
mental interrogation of the cellular SCN, including intersectional
approaches. As examples, such approaches would help address
clear knowledge gaps that exist with respect to (1) molecular
heterogeneity within other canonical SCN cell populations (e.g.,
AVP, NMS), (2) how temporal information (phase) is synapti-
cally communicated to downstream effector networks, (3) the
behavioral state activity dynamics of different SCN cell popula-
tions, and (4) how the various SCN cell populations, including
functional subpopulations, are regulated synaptically by sensory
flow to modulate fundamental properties of the circadian clock
such as phase, amplitude and period. Hence, for example, future
CRACM work using other Cre-driver mouse lines, including the
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development of newer lines informed by cell-type specific tran-
scriptomics63, will facilitate the development of a comprehensive
map of SCN synaptic outflow. In turn this will enable a more
detailed understanding of the circuit and synaptic bases by which
various SCN cell populations impart temporal organization on a
broad range of physiological and behavioral outputs.
Methods
Generation and validation of VIP-IRES-Cre mice. VIP-IRES-Cre mice were
generated using standard recombineering techniques14. In brief, a selection cassette
containing an optimized internal ribosomal entry sequence linked to Cre recom-
binase and a Frt-flanked kanamycin resistance gene was targeted 3 bp downstream
of the stop codon of the VIP gene in a bacterial artificial chromosome (RP24-
216N8; Children’s Hospital Oakland Research Institute). A targeting plasmid
containing the Cre-containing selection cassette and ~4 kb genomic sequence
upstream and downstream of the Vip stop codon was isolated and used for
embryonic stem cell targeting by the Beth Israel Deaconess Transgenic Core.
Correctly targeted clones were identified by long range PCR. Chimeric animals
generated from blastocyst implantation were then bred for germline transmission
of the VIP-IRES-Cre allele. Flp-deleter mice were then used to remove the neo-
mycin selection cassette. Mice were subsequently intercrossed to generate homo-
zygous Cre reporter strains and bred to the R26-loxSTOPlox-L10-GFP reporter
line64. Results from the reporter cross indicated that expression of the transgene
was restricted to the ventrolateral (core) SCN (Fig. 1a). In the VIP-IRES-Cre::L10-
GFP cross we also confirmed the presence of a previously described population of
VIP neurons in the preoptic region, ~1 mm rostral to the SCN. Given the relative
proximity of the preoptic and SCN VIP populations, we constrained the volumes of
our AAV injections targeting the SCN to avoid concurrent transfection of the
preoptic VIP cell population. We subsequently confirmed that the preoptic VIP
population is transcriptionally unique from the SCN VIP cell population and, per
fiber photometry, exhibits markedly different population cell activity dynamics
across the 24 h day and does not respond to an administration of a light pulse (see
Fig. S9).
Stereotaxic brain injections. For selective ablation of SCNVIP and SCNAVP
neurons, VIP-IRES-cre and AVP-IRES-Cre mice received bilateral injections of
AAV10-hSyn-mCherry-DIO-DTA (DTA-AAV; 30-40 nl per side, acquired from
PMF) into the SCN. The DTA vector was created by Drs. Patrick Fuller and
Michael Lazarus, has undergone extensive validation, is published21,22, and is freely
available upon request (as plasmid or AAV). Following injections of DTA-AAV,
and per prior validation studies with this viral-based toxin, we allowed at least
4 weeks for the lesion to develop before starting the LD portion of our recordings.
For chemogenetic experiments, AAV10-EF1α-DIO-hM3Dq-mCherry (30-40 nl
per side; acquired from PMF27, was injected into the bilaterally into the SCN in
VIP-IRES-Cre mice.
For ChR2-assisted circuit mapping (CRACM) experiments, we injected VIP-
IRES-Cre mice (n= 5) unilaterally with 30 nl of AAV-DIO-ChR2-mCherry (UNC
vector core) and placed a second injection of 10 nl of Fluorescent-conjugated
Cholera Toxin Subunit B (F-CTB; green Alexa Fluor-488 conjugated-CTB;
Invitrogen) into the ipsilateral DMH of the same mice, to retrogradely label SPZ
neurons projecting to the DMH.
For photometry experiments, AAV10-EF1α-DIO-GCaMP6s (40 nl; acquired
from PMF65 was injected into the left SCN in male VIP-IRES-Cre mice.
For monosynaptic retrograde modified rabies tracing we first made injections of
a mixture of 60 nl AAV8- EF1ɑ -DIO-TVA (UNC vector core) and 60 nl AAV8-
CAG-DIO-RG (GVVC-AAV-59, Stanford vector core) into the left SCN. Four
weeks after the initial surgeries, 200 nl of EnvA-ΔG-eGFP (Salk Institute) was
injected into the same place.
In brief, mice were anesthetized with a ketamine/xylazine mixture (100 and
10 mg/kg, respectively, IP) and administered slow release meloxicam
subcutaneously (4 mg/kg) for pain relief. Fur was removed from the top of the skull
with clippers and the area sterilized with iodopovidone, followed by isopropyl
alcohol. The mouse was secured in a stereotaxic frame and an incision was made
down the midline of the skull and the skin was retracted to expose bregma. A small
burr hole was drilled through the skull above the SCN and a fine glass pipette
containing the viral vector was slowly lowered down to the SCN (AP: −0.4 from
Bregma, DV: −5.0, ML: 0.3, using coordinates derived from the atlas of Paxinos
and Franklin)66 using a Kopf high precision micro-manipulator. Viral vector was
dispelled slowly at a rate of <1 nl/second using a pico-spritzer air puffer system.
Once the required volume of virus had been dispelled, the pipette was left in
position for 3 min before being slowly raised out of the brain. For CRACM
experiments, a second injection of F-CTB was made into the DMH (AP: −1.6 mm,
DV: −3.5 mm, ML: −0.2 mm) during the same surgery. The skin was sutured back
together and 0.5 ml sterile saline administered subcutaneously before the mouse
was allowed to resume consciousness on a heating pad.
Biotelemetry implantations and recordings. Mice were anesthetized with keta-
mine/xylazine [100 and 10 mg/kg respectively, intraperitoneal (IP)]. An incision
was made in the IP cavity and biotelemetry transmitters (ETA-F10, Data Sciences
International, St. Paul, MN) were implanted. Incisions were sutured and treated by
topical antibiotic. After at least two weeks of implantation, mice were housed in
standard cages placed atop a biotelemetry receiver, interfaced to a microcomputer
data acquisition system (Data Sciences International), in an insulated sound-
proofed recording chamber maintained at an ambient temperature of 22 ± 1 °C and
on a 12 h light 12 h dark cycle (lights-on at 7 A.M., Zeitgeber time: ZT0) with food
and water available ad libitum. Mice were habituated to these chambers for at least
three days before recording. Body temperature values were recorded at 5-min
intervals, and LMA data were collected in 5-min bins. Mice were recorded for at
least 10 days under an LD cycle, followed by at least 3 weeks in DD, and then
returned to LD conditions for at least 7 days. LMA and Tb data were first analyzed
and plotted using Clocklab (Coulbourne Instruments, Natick, MA). For each
mouse, we obtained LMA and Tb rhythm period (Chi-squared periodogram) and
cosinor amplitude for the last 7 days in LD and the last 7 days in DD. The phase
angle of entrainment (Ψ) was calculated as the difference (in hours) between the
light-dark transition (ZT 12) and the acrophase of the rhythm. The acrophase of
the Tb and LMA rhythms were calculated from a least squared fit during the last
7 days of LD. Chi-square periodograms were generated from the last 7 days of
wheel-running data in constant darkness. The largest peak in the periodogram in
the range of 12–36 h was selected as the circadian period. The amplitude of this
peak was used in subsequent analysis as a proxy for the degree of circadian
rhythmicity in individual animals.
Running wheels. Mice were housed in individual cages equipped with running
wheels with free access to food and water. The cages were placed in an environ-
mental chamber (Percival Scientific, Perry, IA) maintained at 20–21 °C on a 12:12 h
light:dark (LD) cycle. The environmental chamber light intensity was approxi-
mately 300 lux during L and 0 lux during D. Wheel rotations were monitored
through magnetic induction, acquired continuously and stored in 5-min bins with
Vitalview software (Mini-Mitter Co.). The mice were maintained in the LD cycle
for at least ten days then placed into constant darkness for 21 days. Finally, a
skeleton photoperiod consisting of one hour of light and 11 h of darkness was
applied. Time series data were imported into Clocklab (Actimetrics) for analysis of
behavioral rhythmicity. Zeitgeber time (ZT) was used to define lights-on and dark
phases during the LD cycle. By convention, ZT12 was defined as lights-off.
Actograms were double-plotted and the display setting was set to ‘scaled’.
Sleep-wake monitoring and analysis. Mice were anesthetized with ketamine/
xylazine [100 and 10 mg/kg respectively, IP] and then placed in a stereotaxic
apparatus. Mice were implanted with four EEG screw electrodes (two frontal and
two parietal electrodes; Pinnacle Technology Inc. #8403) and two flexible elec-
tromyogram (EMG) wire electrodes (Plastics One #E363/76/SPC) previously sol-
dered to a 6-pin connector (Heilind Electronics, Inc. #853-43-006-10-001000) and
the assembly was secured with dental cement32. The frontal electrodes were
positioned 1 mm frontal and 1 mm lateral from bregma whereas the parietal
electrodes were positioned 1 mm lateral from bregma and midway between bregma
and lambda.
Two weeks after EEG/EMG implantation, the mice were housed individually in
transparent barrels in an insulated sound-proofed recording chamber maintained
at an ambient temperature of 22 ± 1 °C and on a 12 h, 12 h or 12 h light/dark cycle
(lights-on at 6 A.M., Zeitgeber time: ZT0) with food and water available ad libitum.
Mice were habituated to the recording cable for 5–7 days before starting
polysomnographic recordings. Cortical EEG (ipsilateral frontoparietal leads) and
EMG signals were amplified and digitalized with a resolution of 500 Hz using
VitalRecorder software (Kissei, Japan). Sleep was recorded in baseline LD
conditions followed by 5 days in constant dark.
Using SleepSign for Animal (Kissei, Japan), and with assistance of spectral
analysis using fast Fourier transform (FFT), polysomnographic records were
visually scored in 10 s epochs for wakefulness, NREM sleep, and REM sleep. The
percentage of time spent in each condition was summarized for each group and
each condition. To study sleep-wake fragmentation we analyzed the distribution of
each vigilance stage in different episode lengths. Vigilance stages were separated
into eight episode lengths (<30, 40–70, 80–150, 160–310, 320–630, 640–1270,
1280–2550, and >2550 s)67,68. For each vigilance stage, the number of episodes and
the percentage of the vigilance stage occurring in each episode length bin were used
to produce a time-weighted frequency histogram.
Recordings were scored again in 5 s epochs to allow for performance of an EEG
power spectrum analysis. On the basis of visual and spectral analysis, epochs
containing artifacts occurring during active wakefulness (with large movements) or
containing two vigilance states were visually identified and omitted from the
spectral analysis. Recordings containing wake artifact for more than 20% of the
analysis period were removed from the spectral analysis. EEG power spectra were
computed for consecutive 5 s epochs within the frequency range of 0.5–120 Hz
using a FFT. The data were collapsed into 0.5 Hz bins and summed in delta, δ:
0.5–5 Hz; theta, θ: 5–9 Hz; sigma, σ: 9–15 Hz; beta, β: 15–30 Hz, low gamma, lγ:
30–60 Hz and high gamma, hγ: 60–120 Hz. For chemogenetics experiments
(Fig. 6d), EEG power spectra were analyzed during the 3 h period of time post
injection, starting 10 min after the injection to capture the complete range of time
in which CNO affects vigilance state as previously described32. The data were
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standardized by expressing each frequency bin as a percentage relative to the same
bin under baseline conditions from the same mouse and from the same time of the
day (same Zeitgeber time). To analyze the FFT across the whole day in VIPcre/cre::
Bmal1fl/fl mice, VIPcre/wt::Bmal1fl/fl mice, AVPDTA mice and VIPDTA mice, the FFT
was analyzed in 3 h periods throughout the 24 h circadian period. The data were
standardized by expressing each frequency band as a percentage relative to the 24 h
frequency band power.
In vivo fiber photometry. A total of 12 heterozygous VIP-ires-Cre mice were used
for photometry experiments. Only mice bearing accurate targeting of the photo-
metry fiber and injection sites are included in the results, hence the final cohort
size of 4.
Surgeries: Two weeks after the viral vector injection of AAV10-DIO-EF1ɑ-
GCaMP6s, the mouse was implanted with a custom-made photometry fiber and
EEG/EMG headset. The photometry fibers were manufactured in-house and
comprised a fiber optic cable (400 µm outer diameter, ThorLabs FP400URT)
inserted into an aluminum ferrule (400 µm internal diameter, ThorLabs SFLC440-
10), epoxied into place (PFP 353ND, Precision Fiber Products), cleaved to size and
polished. The EEG headset was also manufactured in-house (as described above),
with the exception that the left frontal electrode screw was removed from the
assembly to allow photometry fiber implantation. The mouse was prepared for
stereotaxic surgery as described above (Stereotaxic brain injections). Once secured
in the stereotaxic frame, the EEG headset was implanted as described above (Sleep-
wake monitoring and analysis). The burr hole over the SCN was reopened and the
photometry fiber was implanted immediately dorsal to the SCN (0.1 mm dorsal to
the injection site). The whole assembly was affixed to the skull using a mixture of
cyanoacrylate glue and dental cement. An additional layer of dental cement was
then applied to insulate the headset and provide structural stability. The mouse was
then allowed to recover for 2 weeks prior to recordings.
Photometry behavioral recordings: Recordings were carried out in a sound-
proofed and light-tight chamber, maintained at a constant temperature and
humidity. Prior to the experimental recordings, mice were kept on a 12:12 light-
dark schedule. Clear, plexiglass barrels were used as the animal’s home cage and
food and water were available ad libitum. Mice were allowed to habituate to the
recording chambers, EEG/EMG cable and photometry patch cable for at least
3 days prior to behavioral recordings before being placed in DD at lights off on the
last day of habituation. Simultaneous EEG/EMG and in vivo fiber photometry
recordings were then made at CT2-5 in the first cycle after the onset of DD and at
CT 12–16 (24 h after the onset of DD). A 20-min light pulse was administered at
CT 14 (26 h after the onset of DD).
Simultaneous EEG/EMG and photometry recording setup and analyses: For
EEG/EMG recordings, the EEG/EMG headset was connected, via a low weight
custom-made cable, to a freely moving electrical commutator. The signal from the
commutator was directed to an AM Systems Model 1700 amplifier (amplifed ×10 K
gain) and digitized at 500 Hz using a Micro-1401-3 (Cambridge Electronic Design).
To simultaneously record the GCaMP6s signal, light from a 465 nm blue LED
(the excitation wavelength for GCaMP6s, LEDC1-B_FC Doric) and a 405 nm UV
LED (LEDC1-405_FC) was directed to a fiber optic mini-cube containing UV and
GFP filters (FMC5_AE(405)_AF(420-450)_E1(460-490)_F1(500-550)_S, Doric)
via a 200 µm, 0.22 NA fiber patch cable. A sample patch cord (400 µm, 0.48 nm)
was mated to the photometry fiber ferrule on the mouse’s head to deliver blue and
UV light to the SCN and collect the emitted fluorescence from GCaMP6s-
expressing cells. This emitted signal was directed back through the filter cube to
two photodetectors (Newport 2151) via 600 µm, 0.66 NA fiber patch cables. The
signal was amplified at the photodetector (DC gain: 2 × 1010) and digitized at 500
Hz (Micro-1401-3, Cambridge Electronic Design). Recordings in which UV
excitation of the tissue resulted in a moving signal that ran parallel to the recorded
calcium-dependent GCaMP6s signal were assumed to be contaminated with
movement artifact and discarded from the analysis. Data were acquired using Spike
2.13 software and sleep-wake states were analyzed offline. For automatic data
scoring, EMG root mean square, EEG delta power and EEG theta:delta ratio were
used to distinguish between sleep states. All sleep records were then manually
scored by an investigator blinded to the experimental conditions.
After behavioral sleep stage scoring, the GCaMP6s signal and sleep staging
timestamps were exported to MATLAB for further analysis. Data were
downsampled to 1 Hz and fitted to a second order exponential curve to correct for
bleaching. This curve was designated as F0 and used to calculate δF/F= Ft-F0/F0,
where Ft denotes the GCaMP6s signal at time t. To normalize fluorescence levels
between mice, δF/F was then processed as a z-score. At transitions, the GCaMP6s
signal was zeroed by calculating the median value of the 60 s preceding the
transition and subtracting this from the GCaMP6s signal throughout the transition
(i.e., 60 s before to 60 s after the transition occurred).
Rabies tracing. For monosynaptic retrograde modified rabies tracing we first made
injections of a mixture of 60 nl AAV8- EF1ɑ -DIO-TVA and 60 nl AAV8-CAG-
DIO-RG into the SCN as described above (Stereotaxic brain injections). Four weeks
after the initial surgeries, 200 nl of EnvA-ΔG-eGFP was injected into the same
place. Mice were perfused 11 days following the second stereotaxic injection and
processed for histology (as described in Immunohistochemistry). In brief, one
entire series was immunolabelled for dsRed to allow visualization of TVA-mCherry
and then mounted. Neurons containing both TVA-mCherry and eGFP were
considered the starter population. Each eGFP positive neuron in the brain was
counted and registered to the mouse atlas of Paxinos and Franklin66. The profile of
afferent inputs is presented as the number of eGFP expressing neurons within a
particular brain region as a percent of the total number of eGFP neurons counted
in the whole brain (the input fraction).
ChR2-assisted circuit mapping (CRACM). For CRACM experiments, we injected
VIP-IRES-Cre mice (n= 5) with of AAV-DIO-ChR2-mCherry unilaterally into the
SCN and placed a second injection of of Fluorescent-conjugated Cholera Toxin
Subunit B (F-CTB; green Alexa Fluor-488 conjugated-CTB; Invitrogen) into the
ipsilateral DMH of the same mice, to retrogradely label SPZ neurons projecting to
the DMH.
Five to six weeks after the AAV and F-CTB injections, mice were sacrificed for
in vitro electrophysiological recordings. Mice were deeply anaesthetized with
isoflurane (5% in oxygen) via inhalation and transcardially perfused with ice-cold
cutting ACSF (N-methyl-D-glucamine, NMDG-based solution) containing (in
mM): 100 NMDG, 2.5 KCl, 1.24 NaH2PO4, 30 NaHCO3, 25 glucose, 20 HEPES, 2
thiourea, 5 Na-L-ascorbate, 3 Na-pyruvate, 0.5 CaCl2, 10 MgSO4 (pH 7.3 with HCl
when carbogenated with 95% O2 and 5% CO2; 310–320 mOsm). Mouse brains
were then quickly removed and sectioned in coronal slices (250 µm thickness) in
ice-cold NMDG-based ACSF using a vibrating microtome (VT1200S, Leica). We
first incubated the slices containing the hypothalamus for 5 min at 37 °C, then we
transferred them into a holding chamber at 37 °C containing normal ACSF (Na-
based solution) for 10 min. Following this two-step incubation we let the brain
slices gradually return to room temperature (~1 h) before transferring them to the
recording chamber where they were submerged and perfused (1.5 ml/min) with
Na-based ACSF. Normal ACSF (Na-based solution) contained (in mM): 120 NaCl,
2.5 KCl, 1.3 MgCl2, 10 glucose, 26 NaHCO3, 1.24 NaH2PO4, 4 CaCl2, 2 thiourea, 1
Na-L-ascorbate, 3 Na-pyruvate (pH 7.3–7.4 when carbogenated with 95% O2 and
5% CO2; 310–320 mOsm). We recorded SPZ neurons (retrogradely labeled with F-
CTB) using a combination of fluorescence and infrared differential interference
contrast (IR-DIC) microscopy. We used a fixed stage upright microscope
(BX51WI, Olympus America Inc.) equipped with a Nomarski water immersion
lens (Olympus 40×/0.8 NAW) and IR-sensitive CCD camera (ORCA-ER,
Hamamatsu, Bridgewater, NJ, USA) and we acquired real time images using
MATLAB (MathWorks) script software. We recorded SPZ neurons in whole-cell
and cell-attached configurations using a Multiclamp 700B amplifier (Molecular
Devices, Foster City, CA, USA), a Digidata 1322A interface, and Clampex
9.0 software (Molecular Devices). Neurons showing changes in input resistance of
greater than 10% over the duration of the recording were excluded from the
analysis. For all recordings, we recorded at a holding potential of 0 mV and using a
Cs-methane-sulfonate-based pipette solution. The Cs-methane-sulfonate-based
pipette solution contained (in mM): 125 Cs-methane-sulfonate, 11 KCl, 10 HEPES,
0.1 CaCl2, 1 EGTA, 5 Mg-ATP and 0.3 Na-GTP (pH adjusted to 7.2 with CsOH,
280 mOsm). For all the recordings, we added 0.5% biocytin in the pipette solutions
to mark the recorded neurons. We photostimulated SCNVIP axon terminals in the
SPZ using a full-field (~10 mW/mm2, 1 mm beam width) blue light-emitting diode
(470 nm wavelength; #M470L2-C4; Thorlabs) coupled to the epifluorescence
pathway of the microscope. We first tested the effects of photostimulation on the
action potential firing of SPZ neurons in cell-attached mode, using train
stimulations (train-duration: 10 s, frequency: 10 Hz, light pulse duration: 10 ms).
We then switched to whole-cell mode (and ACSF containing 1 mM of kynurenic
acid). To record IPSCs, we applied 10 ms light pulses (0.1 Hz, for a minimum of 30
trials) to the brain slice in order to elicit photo-evoked IPSCs. At the end of the
recordings, recorded slices and adjacent slices containing the AAV and F-CTB
injection sites were fixed overnight in 10% buffered formalin for further
histological processing.
CRACM Data analysis. Recording data were analyzed using Clampfit 10 (Mole-
cular Devices), MiniAnalysis 6 software (Synaptosoft) and MatLab (MathWorks)
software. Figures were generated using Igor Pro version 6 (WaveMetrics), Prism 7
(GraphPad) and Photoshop (Adobe) software. To ensure unbiased detection of the
synaptic events, the IPSCs were detected and analyzed automatically using Min-
iAnalysis. We considered SPZ neurons to be responsive to photostimulation if their
IPSC probability during the first 50 ms following the light pulses was greater than
50% (baseline IPSC probability= 21.08 ± 3.15%, n= 20)69. We calculated the
latency of the photo-evoked IPSCs as the time difference between the start of the
light pulse and the 5% rise point of the first IPSC70.
Immunohistochemistry. Mice were sacrificed by deep anesthesia with 200 mg/kg
of chloral hydrate, and transcardially perfused with 20 ml saline, followed by
100 ml of neutral phosphate buffered formalin (4%, Fischer Scientific Co.). Brains
were removed, incubated in 20% sucrose at 4 °C until they sank, and then sectioned
at 40 µm on a freezing microtome in three series. Sections were washed in phos-
phate buffered saline (PBS), and incubated in primary antiserum (dsRed rabbit
polyclonal antibody (1:10 K; Clontech; catalog number 632496), AVP antibody
(1:8K; Peninsula Lab, LLC catalog number T-5048), VIP antibody (1:10K; Milli-
pore, catalog number AB983), or hrGFP rabbit polyclonal antibody (1:10 K;
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Vitality; 240142-51) diluted in PBS containing 0.3% Triton X-100 (PBST) and 0.2%
sodium azide for one day at room temperature. For fluorescent detection of pri-
mary antibodies, sections were washed three times in PBS and incubated in
fluorescent secondary antiserum for 2 h (against appropriate species IgG, 1:500,
Jackson ImmunoResearch). Sections were then washed twice in PBS before being
mounted on positive charged slides (Denville Scientific, Inc) and imaged on an
Olympus BX61VS slide scanner or Zeiss LSM 5 Pascal confocal microscope. For
mice injected used for retrograde rabies tracing experiments, the retinas were
removed following perfusion and incubated in 20% sucrose at 4 °C until they sank.
The retina was sliced rostral-caudally in 10 µm slices on a cryostat and retinal
sections were collected directly onto positively charged slides (Denville Scientific,
Inc) that had been pre-subbed in 1% gelatin solution, before imaging native eGFP.
For brain slices used for CRACM experiments, we further processed the
recorded SCN-SPZ containing slices over-night with streptavidin-conjugated Alexa
Fluor-405 (blue; 1: 500; Invitrogen)21 to label the recorded SPZ neurons filled with
biocytin. We then wet mounted brain slices containing the SCN and DMH and
imaged them using a Zeiss LSM 5 Pascal confocal microscope and Zen
2009 software (Zeiss), and mapped the distribution of the SPZ recorded neurons
onto a template image. We also projected the F-CTB injection sites from each
mouse onto a series of standardized sections66 and compiled these using a custom-
made Python script (www.python.org)71 in order to construct a heatmap.
sNuc-Seq. sNuc-Seq Data Generation: Six-week old (juvenile; n= 2) and 10-week
old (adult, n= 1) VIP-IRES-Cre::H2b-TRAP male siblings were bred from the same
VIP-IRES-Cre x H2b-TRAP mouse line. One hour after light cycle onset, the VIP-
IRES-Cre::H2b-TRAP mice were removed from their home cage and rapidly
decapitated in order to minimize stress-related changes in gene expression. Brains
were extracted quickly, chilled briefly in ice-cold DMEM/F12 media, and then
sectioned coronally at 1-mm intervals in a chilled stainless steel brain matrix. The
brain sections containing the SCN and sections adjacent to the SCN were collected
in ice-cold RNAlater (Qiagen catalog # 76106). Each section was imaged using a
fluorescence stereoscope (Zeiss Discovery V8) in order to visualize fluorescently
labeled cells in the SCN for dissection. Dissected tissue was pooled across mice by
age group (juvenile, adult) and placed into ice-cold RNAlater overnight in the dark
at 4 °C. The following morning, the RNAlater-preserved tissue samples were
processed into single-nuclei suspensions according to the sNuc-Seq method of
Habib et al.42. In brief, the two SCN tissue samples (juvenile, adult) were Dounce
homogenized (Wheaton tissue grinders, catalog # 357538) and separated by density
gradient centrifugation as described in the published protocol42. Each pellet was
then re-suspended in 0.5 mL sNuc-Seq resuspension buffer42 and filtered through a
20 μm mesh (Miltenyi Biotec pre-separation filters, catalog # 130-101-812) to
remove clumped nuclei and larger debris. Nuclei were counterstained with two
drops of NucBlue Live ReadyProbes Reagent (ThermoFisher Scientific catalog #
R37605) per mL of nuclei. Nuclei were sorted by MoFlo Astrios EQ cell sorter
(Harvard Bauer core facility), gating for NucBlue+ /mCherry+ singlets and dis-
tributing them individually to wells of 96-well plates containing 5 μL per well of
nuclei capture buffer (1% beta-mercaptoethanol in Qiagen Buffer TCL; catalog #
1031576). Each plate was loaded with equal numbers of samples from juvenile and
adult SCN tissue. Loaded plates were centrifuged for 5 min at 2500 × g and 4 °C to
ensure nuclei reached the capture buffer and frozen at −80 °C for up to 4 weeks
until use. Sample plates were transferred to an RNA-dedicated PCR cabinet,
thawed quickly, and immediately purified with RNA-Clean XP (Beckman Coulter,
catalog # A63987; 2.5:1 ratio of RNA-Clean XP to sample volume), eluting in 4 μL
Smart-seq2 buffer (2 μL Smart-seq2 cell lysis buffer, 1 μL 100 μM oligo-dT primer,
and 1 μL 10 mM dNTP mix)72. cDNA was then generated and amplified as
described in the Smart-Seq2 protocol72, except that 22 PCR cycles were used for the
amplification step. After the PCR step, 10 μL of each sample was transferred to new
96-well plates for subsequent processing. Amplified cDNA was purified with two
rounds of SPRIselect (Beckman Coulter, catalog # B23318; 0.8:1 ratio of SPRIselect
to sample volume), eluting in ultrapure water. cDNA concentration was measured
by Qubit fluorometry in a microplate format, each well containing 2 μL of cDNA
sample and 98 μL of Qubit working solution (ThermoFisher Scientific, catalog #
Q32854). Qubit readings were collected with a fluorescence microplate reader
(Molecular Devices SpectraMax M5; Harvard Medical School ICCB-Longwood
core facility) and used to calculate DNA concentrations by comparing each sam-
ple’s Qubit reading to standards in a 50% dilution series (n= 8 standards; range,
0.25–0.01 ng/μL plus a negative control, 0.0 ng/μL). cDNA samples were then
diluted to 0.15 ng/μL with ultrapure water and processed into sequencing libraries
with sample-specific indices using the Nextera DNA Sample Prep Kit and Nextera
XT Index Kit v2 sets A–D (Illumina, catalog #s FC-131-1096, FC-131-2001, FC-
131-2002, FC-131-2003, FC-131-2004, respectively). Nextera XT was used at ¼
reaction volumes but otherwise according to manufacturer’s instructions.
Sequencing libraries were purified with two rounds of SPRIselect (0.8:1 ratio of
SPRIselect to sample volume) and eluted in a single volume of ultrapure water.
Library pool concentration was measured by Qubit according to the manufacturer’s
instructions, sized using Agilent BioAnalyzer high sensitivity kit, and then diluted
with ultrapure water to a size-corrected concentration of 2 nM. The diluted library
pool was denatured and further diluted to 2pM loading concentration according to
Illumina NextSeq recommendations, then sequenced with a NextSeq 500 v2
75cycle sequencing kit (Illumina, catalog # FC-404-2005).
sNuc-Seq data processing. Base calls and demultiplexing were performed with
bcl2fastq2 v2.20.0. Reads were aligned to the mouse genome (build: mm10,
GRCm38) by HISAT2 v2.1.0 (using “-k 2”)73. Aligned reads were converted to
BAM using SAMtools v1.8.074. Duplicate and low-quality reads were removed with
Picard 2.17.0 (http://broadinstitute.github.io/picard). Reads were assigned to
features (genes) using the feature Counts from the Subread package v1.6.0 (using
recommended setting and a custom meta-annotation that merges overlapping
isoforms)75. Expression values were calculated by counting the reads assigned to
each gene.
sNuc-Seq data analysis. Clustering and cluster marker analyses were performed
in Seurat v2.3.476 using the standard workflow and default settings except where
indicated. First, the gene expression values were imported and log-normalized.
Highly variable genes (n= 943) were selected with Seurat’s FindVariableGenes
function for having higher ratios of dispersion relative to mean expression. These
highly variable genes were used for principal component analysis (PCA) with
Seurat’s RunPCA function. Transcriptomes were then clustered across the first 10
principal components (PCs) using Seurat’s FindClusters function, resolution set to
1. Clusters were numbered based on their position in hierarchical clustering
dendrogram. To identify cluster markers, differential expression analysis was
performed with Seurat’s FindAllMarkers function under default settings. Clusters
were assigned as “SCN” or “non-SCN” based on the anatomical expression patterns
of top cluster markers observed in the Allen Mouse Brain Atlas77 (Lhx1; Vipr2;
Reln; Ecel1). The SCN clusters were re-clustered by excluding the non-SCN cluster
and then repeating the workflow described above, beginning with the variable gene
selection (689 variable genes used for PCA, 12 PCs used for clustering).
Plots were generated with Seurat v2.3.4 and pheatmap v1.0.12 packages for R.
VIP RNAScopeTM in situ hybridization. RNAScopeTM in situ hybridization was
performed to label VIP mRNA in mouse brain tissue. For this, 30 μm SCN brain
sections were cut on a freezing microtome and mounted on Superfrost Plus slides
in RNAse free conditions. RNAscope hybridization was performed on these sec-
tions using the RNAScope Multiplex Flourescent Reagent Kit V2 (Catalog #
323100, Advanced Cell Diagnostics). The sections were then pretreated with
hydrogen peroxide for 20 min in room temperature and target retrieval was per-
formed by placing the slides in a steamer at 99 °C for 5 min. Next, sections were
dehydrated in 100% alcohol and air-dried for 5 min. Sections were then treated
with protease reagent (Protease III, RNAscope) for 30 min at 40 °C. After rinsing in
sterile water, sections were incubated in RNAscope probe for VIP-C1 (RNAscope®
Probe- Mm-Vip;Cat No. 415961;Advanced Cell Diagnostics) for 2 h at 40 °C for
the hybridization reaction to occur. Sections were then subjected to three ampli-
fication steps at 40 °C (AMP1-FL and AMP2-FL: 30 min each; AMP3-FL: 15 min)
followed by incubation in HRP –C1 for 15 min. Sections were then incubated in
TSA plus Fluorescein fluorophore (Catalog # NEL741001, Perkin Elmer) for
30 min at 40 °C to enable visualization of VIP mRNA in green. Finally, slides were
incubated in HRP blocker for 15 min at 40 °C before being dried overnight and
cover-slipped using Vectashield mounting medium (Catalog # H-1400, Vector
laboratories).
Statistics. All statistics were carried out using Prism v6 or v7 (GraphPad software)
unless otherwise indicated. For our circadian variables in our crossed mice (Fig. 1),
one-way ANOVAs were used to determine group differences across phenotypes in
these values, with Sidak tests serving as post hoc analyses. For our cell-specific
ablations experiments, unpaired t tests were used to determine differences between
VIPDTA and AVPDTA mice (Fig. 3). For sleep-wake analyses (Figs. 2, 4, 6, S5, S6, S7,
S8): following confirmation that the data met the assumptions of the ANOVA
model, two-way ANOVA followed by a post hoc Bonferroni test were used to
compare the effects of genotype or drug injection and time period on sleep-wake
parameters, the effect of genotype or drug injection and the distribution of vigi-
lance episodes, or the effect of genotype or drug injection and cortical EEG power
density. The individuals performing the sleep-wake analysis were blinded to the
initial immunohistochemical assessment of the injection sites and to the mouse
genotype.
For photometry experiments (Fig. 7 and S9): to quantify the effect of the light
pulse or of a state transition upon GCaMP6s activity, the mean GCaMP6s signal
was averaged during the 10 seconds preceding the light pulse or the state transition
and compared with GCaMP6s signal averaged 10 s afterwards. Statistical analyses
were carried out using paired t-tests. To quantify GCaMP6s activity during
different states and/or at different times, the GCaMP6s signal was averaged over
the duration of the state and compared using repeated measures one-way ANOVA
or repeated measures two-way ANOVA, utilizing a post hoc Sidak test where
applicable.
For retrograde rabies tracing (Fig. 9), we repeated this experiment on n= 3
different mice. In two of the mice, there was some leakage of the starter population
into the rostrally adjacent VMPO, therefore we only quantified % inputs to SCN
neurons for n= 1 mouse.
Sample size and power calculations were performed post hoc at http://www.
biomath.info, using means and standard deviations derived from our analysis. The
present study was sufficiently powered to detect effect sizes.
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